| Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 H Wang, KR Paulson, SA Pease, S Watson, H Comfort, P Zheng, ... The Lancet 399 (10334), 1513-1536, 2022 | 1422 | 2022 |
| Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1 … TJ Bollyky, EN Hulland, RM Barber, JK Collins, S Kiernan, M Moses, ... The Lancet 399 (10334), 1489-1512, 2022 | 392 | 2022 |
| Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis RM Barber, RJD Sorensen, DM Pigott, C Bisignano, A Carter, JO Amlag, ... The Lancet 399 (10344), 2351-2380, 2022 | 250 | 2022 |
| Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial L Verlingue, D Malka, A Allorant, C Massard, C Ferté, L Lacroix, ... European Journal of Cancer 87, 122-130, 2017 | 159 | 2017 |
| Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: A systematic analysis RJD Sorensen, RM Barber, DM Pigott, A Carter, CN Spencer, SM Ostroff, ... The Lancet 399 (10334), 1469-1488, 2022 | 127 | 2022 |
| Molecular screening for cancer treatment optimization (MOSCATO-01) in pediatric patients: a single-institutional prospective molecular stratification trial AC Harttrampf, L Lacroix, M Deloger, F Deschamps, S Puget, N Auger, ... Clinical Cancer Research 23 (20), 6101-6112, 2017 | 114 | 2017 |
| Can we trust the calculation of texture indices of CT images? A phantom study C Caramella, A Allorant, F Orlhac, F Bidault, B Asselain, S Ammari, ... Medical Physics 45 (4), 1529-1536, 2018 | 55 | 2018 |
| Heirs, corporate aristocrats and ‘Meritocrats’: The social space of top CEOs and chairmen in India J Naudet, A Allorant, M Ferry Socio-Economic Review 16 (2), 307-339, 2018 | 29 | 2018 |
| Short-term effects of the COVID-19 pandemic on HIV care utilization, service delivery, and continuity of HIV antiretroviral treatment (ART) in Haiti K Celestin, A Allorant, M Virgin, E Marinho, K Francois, JG Honoré, ... AIDS and behavior 25, 1366-1372, 2021 | 22 | 2021 |
| Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): What are the real risks? C Prud'Homme, F Deschamps, A Allorant, C Massard, A Hollebecque, ... European Journal of Cancer 103, 108-119, 2018 | 22 | 2018 |
| Introduction. Towards a sociology of India’s economic elite: Beyond the neo-orientalist and managerialist perspectives SS Jodhka, J Naudet South Asia Multidisciplinary Academic Journal, 2017 | 14 | 2017 |
| Closing the gap in implementation of HIV clinical guidelines in a low resource setting using electronic medical records A Allorant, C Parrish, G Desforges, E Robin, JG Honore, N Puttkammer BMC Health Services Research 20, 1-12, 2020 | 4 | 2020 |
| Finding gaps in routine TB surveillance activities in Bangladesh A Allorant, S Biswas, S Ahmed, KE Wiens, KE LeGrand, MM Janko, ... The International Journal of Tuberculosis and Lung Disease 26 (4), 356-362, 2022 | 3 | 2022 |
| Temporal trends and determinants of HIV testing at antenatal care in Sub-Saharan Africa: a pooled analysis of population-based surveys (2005–2021) A Allorant, P Muset, C Hodgins, F Kirakoya-Samadoulougou, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 95 (1S), e97-e105, 2024 | 2 | 2024 |
| Corrigendum to" Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial"[Eur J Cancer 87 (2017) 122-130] L Verlingue, D Malka, A Allorant, C Massard, C Ferté, L Lacroix, ... European journal of cancer (Oxford, England: 1990) 93, 156-157, 2018 | 1 | 2018 |
| Héritiers, aristocrates d’entreprise et «méritocrates»: l’espace social du grand patronat en Inde J Naudet, A Allorant, M Ferry Entreprises et histoire, 88-105, 2018 | 1 | 2018 |
| Comparison of Wealth-Related Inequality in Tetanus Vaccination Coverage before and during Pregnancy: A Cross-Sectional Analysis of 72 Low-and Middle-Income Countries NE Johns, C Blumenberg, K Kirkby, A Allorant, FDS Costa, ... Vaccines 12 (4), 431, 2024 | | 2024 |
| A small area model to assess temporal trends and sub-national disparities in healthcare quality A Allorant, N Fullman, HH Leslie, M Sarr, D Gueye, E Eliakimu, ... Nature Communications 14 (1), 4555, 2023 | | 2023 |
| A methodological framework to assess temporal trends and sub-national disparities in healthcare quality metrics using facility surveys, with applications to sick-child care in … A Allorant, N Fullman, HH Leslie, M Sarr, DM Gueye, E Eliakimu, ... medRxiv, 2022.07. 19.22276796, 2022 | | 2022 |
| Measuring inequities in health service delivery and their impact on health outcomes in low-to middle-income countries A Allorant University of Washington, 2021 | | 2021 |
